Research never stops

Archive



Feb 02, 2016

Evotec awarded grant from The Michael J. Fox Foundation for Parkinson's Research

Hamburg, Germany - 02 February 2016: Evotec AG today announced that it has been awarded a research grant from The Michael J. Fox Foundation to further develop Evotec's TargetaSN (Targetalpha-synuclein) programme for the treatment of Parkinson's disease.

- read more
Jan 12, 2016

Evotec achieves important milestone in TargetAD collaboration with Janssen in Alzheimer's disease

Hamburg, Germany - 12 January 2016: Evotec AG today announced the achievement of an important milestone in its TargetAD collaboration with Janssen Pharmaceuticals, Inc. for the transition of a project into further drug discovery process.

- read more
Jan 07, 2016

Evotec and UCB sign multi-year sample management agreement

Hamburg, Germany - 07 January 2016: Evotec AG today announced an EVT Execute collaboration aimed at providing a complete solution to UCB's global sample management requirements.

 

Watch a short video clip on this press release

- read more